BIOMAT Database Logo BIOMAT Database Logo

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. 2021

Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Herein, a new wave of bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives have been successfully designed and synthesised. The synthesised derivatives were biologically investigated for their cytotoxic activities against HepG2 and MCF-7. Also, the tested compounds were further examined in vitro for their VEGFR-2 inhibitory activity. The most promising derivative 23j was further investigated for its apoptotic behaviour in HepG2 cell lines using flow cytometric and western-plot analyses. Additional in-silico studies were performed to predict how the synthesised compounds can bind to VEGFR-2 and to determine the drug-likeness profiling of these derivatives. The results revealed that compounds 23a, 23i, 23j, 23l, and 23n displayed the highest antiproliferative activities against the two cell lines with IC50 values ranging from 6.4 to 19.4 µM. Furthermore, compounds 23a, 23d, 23h, 23i, 23j, 23l, 23 m, and 23n showed the highest VEGFR-2 inhibitory activities with IC50 values ranging from 3.7 to 11.8 nM, comparing to sorafenib (IC50 = 3.12 nM). Moreover, compound 23j arrested the HepG2 cell growth at the G2/M phase and induced apoptosis by 40.12% compared to the control cells (7.07%). As well, such compound showed a significant increase in the level of caspase-3 (1.36-fold), caspase-9 (2.80-fold), and BAX (1.65-fold), and exhibited a significant decrease in Bcl-2 level (2.63-fold).

UI MeSH Term Description Entries
D011810 Quinoxalines Quinoxaline
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
July 2021, Bioorganic chemistry,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.
September 2021, Bioorganic chemistry,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
August 2002, Archiv der Pharmazie,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
October 2017, Bioorganic & medicinal chemistry letters,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants.
March 2009, European journal of medicinal chemistry,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors.
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation.
October 2022, Archiv der Pharmazie,
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
March 2019, Molecules (Basel, Switzerland),
Nawaf A Alsaif, and Mohammed S Taghour, and Mohammed M Alanazi, and Ahmad J Obaidullah, and Abdulrahman A Al-Mehizia, and Manal M Alanazi, and Saleh Aldawas, and Alaa Elwan, and Hazem Elkady
Discovery and evaluation of novel synthetic 5-alkyl-4-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carbox-amide derivatives as anti-inflammatory agents.
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!